-
admin
Posts
LoveStudy AI Launches AI-Powered Flashcard, Quiz & Notes Tool to Cut Study Time in Half
SHERIDAN, Wyo., April 22, 2025 /PRNewswire/ — LoveStudy AI, an innovative online learning platform, officially launches today, empowering students worldwide to study smarter, not harder....
Azazie Makes a Statement at London’s National Wedding Show with Bold Bridal Looks and the UK’s Largest Pop-Up Experience
LONDON, April 22, 2025 /PRNewswire/ — This April, Azazie, the global leader in online bridalwear, made an unforgettable impression at The National Wedding Show at...
NAVER D2SF Invests in Virtual IP and Content Startup “SCON”
– Possesses specialized content planning and production capabilities for virtual IP … Currently pursuing both IP development/planning and B2B solutions business– Has debuted the largest...
Tokyo Lifestyle Co., Ltd. Announces Opening of a New Reiwatakiya Directly-Operated Store in Toronto, Canada
Tokyo, Japan, April 21, 2025 (GLOBE NEWSWIRE) — Tokyo Lifestyle Co., Ltd. (“Tokyo Lifestyle” or the “Company”) (Nasdaq: TKLF), a retailer and wholesaler of Japanese...
United Arab Emirates Convenience Retailers Industry Report 2025
Dublin, April 21, 2025 (GLOBE NEWSWIRE) — The “Convenience Retailers in the United Arab Emirates” report has been added to ResearchAndMarkets.com’s offering. Convenience retailers in...
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages e.l.f. Beauty, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELF
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of e.l.f. Beauty, Inc....
Reflect Scientific Inc. Announces Strategic Market Transition and Substantial Cost Savings
OREM, Utah, April 21, 2025 (GLOBE NEWSWIRE) — Reflect Scientific Inc. (symbol: RSCF), a leading innovator in advanced refrigeration and cooling technologies, today announced significant...
Tempest Receives Orphan Drug Designation from the FDA for TPST-1495 to Treat Patients with FAP
BRISBANE, Calif., April 21, 2025 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics to fight...
ORYZON Continues to Strengthen its Patent Portfolio for Vafidemstat
New “Decision to grant” communications in Europe and Japan MADRID and CAMBRIDGE, Mass., April 21, 2025 (GLOBE NEWSWIRE) — Oryzon Genomics, S.A. (ISIN Code: ES0167733015,...
Compass Therapeutics Announces First Patient Dosed in an Investigator Sponsored Trial of Tovecimig in the First-Line Setting for Patients with Biliary Tract Cancer
BOSTON, April 21, 2025 (GLOBE NEWSWIRE) — Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, announced the first patient...
